Ads
related to: renal cell carcinoma- How This Treatment Works
Learn More About How This
FDA-Approved Treatment Works.
- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Clinical Trial Info
Review Clinical Trial Results For
This FDA-Approved Treatment Option.
- Dosing Information
Get Dosing And Treatment
Schedule Information.
- How This Treatment Works
Search results
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 2 days agoEditor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead...
Multiphase comparative study for WHO/ISUP nuclear grading diagnostic model based on enhanced CT...
Nature· 4 days agoTo compare and analyze the diagnostic value of different enhancement stages in distinguishing low and high nuclear grade clear cell renal cell ...
Exelixis (EXEL) Down 6.6% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 12 hours agoCabometyx (cabozantinib) generated revenues of $376.4 million, which missed the Zacks Consensus...
Factor Bioscience Successfully Defends Three U.S. Patents Covering Foundational Methods for...
KOLR - KSFX Ozarks· 3 days ago-Patented methods relate to multiple allogeneic CAR T-cell therapies under clinical development for the treatment of B-cell lymphoma, chronic lymphocytic leukemia, multiple myeloma, and < ...
Nimbus reports positive data from Phase I/II solid tumour therapy trial
Clinical Trials Arena via Yahoo Finance· 7 days agoAccording to the results, 16.7% of response-evaluable patients experienced clinical benefits from...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 3 days agoModerna/Merck also started two separate mid-stage studies in renal cell carcinoma and...
Galvanize Therapeutics' endoscopic, pulsed-field needle scores FDA clearance in cancer, soft tissue...
FierceBiotech· 2 days agoPulsed field ablation has been making waves in cardiac procedures in the past few months following a...
Director Julie Smith Sells 27,280 Shares of Exelixis Inc (EXEL)
GuruFocus.com via Yahoo Finance· 7 days agoThe company is known for its product Cabometyx, which is used in the treatment of various forms of...
Clinical-stage cancer biotech Actuate latest to eye summer IPO
FierceBiotech· 3 days agoCould the IPO window really be reopening for the summer? The second biotech proposition in May seems...
DRAIC mediates hnRNPA2B1 stability and m6A-modified IGF1R instability to inhibit tumor progression -...
Nature· 2 days agoType 1 insulin-like growth factor receptor (IGF1R) plays an important role in cancer, however, posttranscriptional regulation such as N6-methyladenosine (m6A) of IGF1R remains unclear. Here, ...
Ads
related to: renal cell carcinoma